Navigation Links
Bevacizumab Combined With Chemotherapy Improves Progression-Free Survival for Patients With Advanced Breast Cancer

n angiogenesis inhibitor prevents the growth of blood vessels from surrounding tissue to a solid tumor.

“Recent clinical trials have shown that anti-angiogenic drugs have a favorable impact on colon and lung cancers,?said NCI Director Andrew C. von Eschenbach, M.D. “This study demonstrates that when patients with recurrent or metastatic breast cancer received bevacizumab in addition to their chemotherapy, the period of time that they lived with their cancer under control was increased. This is an important step in our journey to ultimately eliminate the suffering and death due to cancer.?/p>

A total of 722 women with recurrent or metastatic breast cancer who had not previously received systemic chemotherapy for their recurrent or metastatic disease were enrolled in this study between December 2001 and May 2004. Patients were randomized to one of the two treatment arms. One patient group received standard treatment consisting of single-agent paclitaxel. The second group received the same regimen of paclitaxel with the addition of bevacizumab.

Patients whose tumors overexpressed HER-2 were not included in the study unless they had previously received trastuzumab (Herceptin? or were unable to receive trastuzumab. Also excluded were patients who had received preventive chemotherapy treatment with paclitaxel within the previous 12 months, as well as patients with a prior history of blood clots or who were on blood thinners. Serious bleeding and blood clots were rare in this study. Patients receiving the combination of paclitaxel and bevacizumab had slightly more neuropathy, or problem in peripheral nerve function (any part of the nervous system except the brain and spinal cord); abnormally high blood pressure; and proteinuria, a condition in which urine contains an abnormal amount of protein, than patients receiving paclitaxel alone. Other side effects were similar between the two treatment groups.

Bevacizumab, a humanized monoclonal antibody*
'"/>

Source:NIH


Page: 1 2 3

Related biology news :

1. Harmful Bacterium Commonly Found in Poultry May Survive Refrigeration and Frozen Storage Combined
2. Combined treatment extends life expectancy for lung cancer patients
3. Adding Radiation Therapy To Chemotherapy Improves Survival In Patients With High-risk Breast Cancer
4. New Treatment Rivals Chemotherapy For Lymphoma, Study Finds
5. Chemotherapy gel may fight breast cancer and reduce breast deformity
6. Chemotherapy temporarily affects the structures of the human brain
7. Cell therapy slows progression of an inherited neurological disease; Improves motor skills in mice
8. Protein That Promotes Survival Of Stem Cells Might Be Key To Poor Leukemia Prognosis
9. Survival of heart patients on beta-blockers varies greatly with genetic variation
10. Survival of the selfless - scientists find cheats dont always prosper
11. Survival of the rarest: Fruit flies shed light on the evolution of behavior
Post Your Comments:
(Date:4/16/2014)... up, and you cannot lift your upper eyelid. You walk ... eyes look straight when they are rolled down in the ... allow people a normal position of their head. In order ... this happens. , In a paper published in the April ... of Iowa researchers Bernd Fritzsch and Jeremy Duncan and their ...
(Date:4/16/2014)... Adam Arkin, director of the Physical Biosciences Division ... a biologist who is recognized as a leading ... networks and populations and their application to systems ... six recipients of the 2013 Ernest Orlando Lawrence ... E.O. Lawrence Award, the Department of Energy (DOE),s ...
(Date:4/16/2014)... Aktories and Dr. Panagiotis Papatheodorou from the Institute of ... of Freiburg have discovered the receptor responsible for smuggling ... into the cell. The TpeL toxin, which is formed ... gas gangrene and food poisoning. It is very similar ... the genus Clostridium . The toxins bind to ...
Breaking Biology News(10 mins):Researchers track down cause of eye mobility disorder 2Berkeley Lab's Adam Arkin wins 2013 Lawrence Award 2Berkeley Lab's Adam Arkin wins 2013 Lawrence Award 3Gate for bacterial toxins found 2
... give the Anne McLaren Memorial Lecture at the UK National Stem ... to screening for drugs that target stem cells. To begin with, ... for new drugs to promote wound healing and aid the use ... can also be applied to a wide range of stem cells, ...
... food source, with a global harvest now at 110 million ... But epidemics of infectious disease threaten this vital industry, including ... Perhaps even more worrisome: these infections can spread to wild ... escaping from them. Heart and skeletal muscle ...
... nanotechnology in the field of drug delivery has attracted ... holds great promise for the development of targeted, localized ... are affected. Such targeted-therapy methods would ... anticancer drugs are distributed throughout the body, attacking healthy ...
Cached Biology News:Top professor will report new way to discover drugs that aid regenerative medicine 2New virus may pose risk to wild salmon 2Researchers use nanoparticles to shrink tumors in mice 2Researchers use nanoparticles to shrink tumors in mice 3
(Date:1/14/2014)... San Diego, CA (PRWEB) January 14, 2014 ... developing solutions based on the products of cells ... they have entered into an international license agreement ... containing Histogen’s proprietary multipotent cell conditioned media (CCM). ... to the existing license between Histogen and Suneva ...
(Date:1/14/2014)... NY (PRWEB) January 14, 2014 ... coverage of Alliqua, Inc. (OTCQB: ALQA). Alliqua is ... marketing proprietary products to serve the wound care ... , In late 2012, Alliqua was restructured with ... the company’s new strategy to become a leading ...
(Date:1/14/2014)... January 14, 2014 iLab Solutions, the ... Detwiler as the new Director of Product Strategy. In ... clients as well as iLab sub-teams to guide in ... be to ensure that iLab provides the maximum possible ... advanced, user-friendly, and high-impact solution in the world. ...
(Date:1/14/2014)... (PRWEB) January 14, 2014 Global ... developing innovative information technology solutions for patients, physicians, ... care stakeholders, announced today the signing of a ... Food and Drug Administration (FDA). This initiative ... related to patient safety, clinical outcomes, and medication ...
Breaking Biology Technology:Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 2Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 3EquitiesIQ Initiates Coverage of Alliqua, Inc. 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 3iLab Solutions Announces Michelle Detwiler as the New Director of Product Strategy 2Global Record Systems Announces Research Collaboration Agreement with FDA to Create a Novel “Big Data” Paradigm for Collection of Patient Safety and Outcomes Information 2
... the Trudeau Institute may help to explain why live ... protection. The research is published in this month,s ... entitled "Live attenuated influenza vaccine (LAIV) impacts innate and ... scientist Dr. Laura Haynes and her colleagues. "Our ...
... ARBOR, Mich.---A delicate balance of atomic forces can be ... size---an attribute that,s important for many nanotech applications but ... The same type of forces are at work ... inorganic supercluster structures in this research are in many ...
... ST. LOUIS, Aug. 23, 2011 Bunge North America, ... BG ), issued the following statement which can be ... "Bunge North America is aware from press ... prior conversations with Syngenta, we are surprised and disappointed that ...
Cached Biology Technology:Trudeau Institute announces a discovery in how FluMist elicits protection 2Engineers discover nanoscale balancing act that mirrors forces at work in living systems 2Bunge Responds to Syngenta Suit 2
Unique enzyme blend containing Taq and Pwo DNA Polymerase and another thermostable enzyme. The Expand 20 kbPLUS PCR System also includes an optimized reaction buffer, MgCl2 solution, and a human cont...
... Antibody This antibody is generated from rabbits ... selected within aa 50~150 of human PLAU. ... with 0.09% (W/V) sodium azide. This antibody ... and eluted out with both high and ...
... mM sodium phosphate buffer, pH 6.5. Cathepsin ... a major lysosomal aspartyl protease in mammalian ... Overexpression of cathepsin D in human breast ... relapse and metastasis. Cathepsin D degrades extracellular ...
Acetate Plate Sealers 100/Box...
Biology Products: